Managing antifungal drugs for invasive aspergillosis in critically ill patients
ManagemEnt of Antifungal Drug in Invasive Aspergillosis：a Real-word Study
This study looks at how critically ill patients with invasive aspergillus infections are treated with antifungal drugs to see how well those treatments work in real life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 550 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Southeast University, China Academic / other |
| Locations | 1 site (Nanjing, Jiangsu) |
| Trial ID | NCT06028451 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the current situation and outcomes of critically ill patients diagnosed with invasive aspergillus infection. By collecting and analyzing data on treatment approaches and patient responses, the study seeks to provide insights into the effectiveness of antifungal therapies in real-world settings. The focus is on understanding how these patients are managed and the results of their treatment.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old who have been diagnosed with invasive aspergillus infection.
Not a fit: Patients who are pregnant will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment strategies for patients suffering from invasive aspergillosis.
How similar studies have performed: While this study focuses on real-world data, similar observational studies have shown promise in improving treatment outcomes for invasive fungal infections.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age\>18 year-old * Diagosed as invasive aspergillus infection Exclusion Criteria: * Pregnant
Where this trial is running
Nanjing, Jiangsu
- Southeast University, Zhongda hospital — Nanjing, Jiangsu, China (Recruiting)
Study contacts
- Principal investigator: Jingyuan Xu, M.D. — Southeast University
- Study coordinator: Jingyuan Xu, M.D.
- Email: 13851417209@163.com
- Phone: 8613851417209
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.